1. Home
  2. HOUR vs GNTA Comparison

HOUR vs GNTA Comparison

Compare HOUR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$1.93

Market Cap

63.3M

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$0.95

Market Cap

34.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
GNTA
Founded
2015
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
34.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HOUR
GNTA
Price
$1.93
$0.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.6K
119.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
128.57
N/A
EPS
0.07
N/A
Revenue
$138,252,861.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.57
N/A
Revenue Growth
4.64
N/A
52 Week Low
$1.10
$0.71
52 Week High
$6.84
$10.00

Technical Indicators

Market Signals
Indicator
HOUR
GNTA
Relative Strength Index (RSI) 56.53 44.16
Support Level $1.73 $0.71
Resistance Level $1.95 $1.70
Average True Range (ATR) 0.08 0.10
MACD 0.01 0.03
Stochastic Oscillator 48.76 58.33

Price Performance

Historical Comparison
HOUR
GNTA

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: